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hSIR2SIRT1 Functions as an NAD-Dependent
p53 Deacetylase
volved in DNA damage responses (Martin et al., 1999;
McAinsh et al., 1999; Mills et al., 1999). These findings
caused us to ask whether the related Sir2 protein of
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The p53 protein is phosphorylated in response to DNA
damage (Siliciano et al., 1997). For example, the ATM
Summary protein phosphorylates p53 at residue Ser15 (Siliciano
et al., 1997) and Chk1/2 kinases modify residue Ser20
DNA damage-induced acetylation of p53 protein leads (Chehab et al., 1999; Shieh et al., 2000). Recent evidence
to its activation and either growth arrest or apoptosis. suggests that the Ser15 phosphorylation does not lead
We show here that the protein product of the gene directly to the functional activation of the p53 protein.
hSIR2SIRT1, the human homolog of the S. cerevisiae Sir2 Instead, it increases the affinity of the p300 acetylase
protein known to be involved in cell aging and in the
for p53 (Lambert et al., 1998). This association leads, in
response to DNA damage, binds and deacetylates the
turn, to the acetylation of p53. Indeed, p53 is acetylated
p53 protein with a specificity for its C-terminal Lys382
in vitro by p300 at Lys 370–373, 381, and 382 (Gu and
residue, modification of which has been implicated in
Roeder, 1997). Moreover, at least two of these sites,the activation of p53 as a transcription factor. Expres-
namely residues 320 and 382, are found to be acetylatedsion of wild-type hSir2 in human cells reduces the
in vivo in response to DNA damage (Abraham et al.,transcriptional activity of p53. In contrast, expression
2000; Sakaguchi et al., 1998). Among other factors thatof a catalytically inactive hSir2 protein potentiates p53-
can affect acetylation of p53 is the MDM2 protein, whichdependent apoptosis and radiosensitivity. We propose
is involved in the negative regulation of p53 (Oren, 1999)that hSir2 is involved in the regulation of p53 function
and is able to block acetylation of p53 protein by p300via deacetylation.
(Kobet et al., 2000). While the acetylation by p300 and
deacetylation by the TSA-sensitive HDAC1 complexIntroduction
(Luo et al., 2000) have been shown to be important in the
positive and negative regulation of p53 protein activity,The Silent Information Regulator (SIR2) family of genes
respectively, the remaining factors responsible for itsis a highly conserved group of genes present in the
regulation as a transcription factor remain elusive.genomes of organisms ranging from archaebacteria to
We have previously shown that analogs of NAD thateukaryotes (Frye, 2000). The encoded SIR proteins are
inhibit endogenous ADP-ribosylases are also able toinvolved in diverse processes ranging from regulation
overcome p53-dependent senescence (Vaziri et al.,of gene silencing to DNA repair. The best characterized
1997). In addition, we demonstrated that p53 proteinof these is the product of the S. cerevisiae SIR2 gene,
can bind to the NAD-dependent poly-ADP-ribose poly-which is involved in silencing HM loci that contain infor-
merase. These observations led us to speculate thatmation specifying yeast mating type, telomere position
other NAD-dependent enzymes, notably Sir2 which waseffects, and cell aging (Guarente, 1999).
known to be involved in life span regulation in lowerIn yeast, SIR2 was thought to function as an NAD
eukaryotes, might also be able to interact with p53.(nicotinamide adenine dinucleotide)-dependent ADP-
For these reasons, we isolated the full-length humanribosyl transferase (Tanny et al., 1999). However, recent
homolog of the Sir2 gene and investigated the functionbiochemical studies have provided evidence that Sir2
functions as a deacetylase which uses NAD as a cofac- of its product in regulating the p53-dependent DNA
tor (Imai et al., 2000; Smith et al., 2000; Landry et al., damage response pathways in mammalian cells. These
2000). experiments revealed unanticipated physical and func-
Among its other functions in S. cerevisiae, Sir2 is in- tional interactions between the Sir2 protein and p53.
Related results are to be found in the report by Luo et
al. (2001) in this issue of Cell.6 Correspondence: weinberg@wi.mit.edu
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Results plexes with p53 protein even without ectopic overex-
pression of these two proteins. To do this, we performed
Physical Interaction of hSir2 with p53 immunoprecipitation of lysates of primary BJ human
Our initial interest in Sir2 was motivated by its reported fibroblasts or MCF-7L human breast cancer cells with
involvement in the DNA damage response and its ability our anti-hSir2 and p53 antibodies as described above
to function as an NAD-dependent ADP ribosylase (Tanny (Figures 1C and 1D). These observations indicated that
et al., 1999); this latter trait allied it with other ADP ribosy- hSir2 and p53 formed physical complexes with each
lases that are activated in response to DNA damage. other in vivo under physiological conditions. However,
However, soon after our work began, the function of no p53 or Sir2 proteins were detected when either a
SIR2 as an NAD-dependent deacetylase was reported control antibody or IgG was used. As an additional con-
(Imai et al., 2000; Smith et al., 2000). Independent of trol, lysates from Saos2 cells (lacking p53 expression)
this, research of others had previously indicated that were subjected to immunoprecipitation in the same set
the p53 protein is acetylated in response to DNA damage of experiments described above. Complexes between
(Abraham et al., 2000; Sakaguchi et al., 1998). These hSir2 and p53 protein were not detectable in these ex-
various findings reoriented our thinking to entertain the periments (Figures 1C and 1D).
possibility that Sir2 acts as a deacetylase of p53, thereby Comparison of the immunoprecipitable hSIR2 protein
downmodulating its function. present in MCF-7L cells with the amount present in pre-
In order to study the possible functional interaction cipitates generated with anti-p53 antibody allowed us to
between p53 and hSir2, we isolated and introduced a estimate that approximately 0.0005% of the total hSir2
full-length human hSIR2SIRT1 cDNA clone (Experimental protein was present in physical complexes with p53
Procedures) into a pBabe-based retroviral expression (Figure 1C). Conversely, we estimated that in MCF-7L
vector that also carries a puromycin resistance gene as cells, approximately 1% of the total p53 could be found
a selectable marker. The resulting construct was termed in physical complexes with the hSIR2 protein (Figure 1D).
pYESir. A retroviral construct bearing a derived, mutant
allele of the hSIR2SIRT1 gene and termed pYESirHY was Deacetylation of p53 by hSir2 In Vitro
constructed and used in parallel. This mutant allele Since hSir2 could form physical complexes with p53,
specifies an amino acid substitution at residue 363 of the we sought to determine whether this protein, a known
hSir2 protein, replacing the normally present histidine by deacetylase, could deacetylate human p53 in vitro. To
tyrosine. We reasoned, by analogy with the Sir2 protein address this question we used bacterially expressed
of yeast (Tanny et al., 1999), that this substitution would murine Sir2, substituted for human Sir2 because of low
result in alteration of the highly conserved catalytic site yields of the human protein. As substrate in these reac-
of the hSir2 protein, the loss of its deacetylase activity, tions, we used a 20 residue-long oligopeptide that con-
and the acquisition of a dominant-negative function. tains the sequence corresponding to residues 368-
These vector constructs were used to express hSir2 by 386Cys of the human p53 protein. The lysine residues
transfection and by retroviral infection. in this oligopeptide corresponding to residues 373 and
We also developed a polyclonal rabbit antibody that 382 of the p53 protein were synthesized in an acetylated
specifically recognizes the C-terminal portion of hSir2;
form. These two residues of p53 are known to be acet-
its specificity was validated both by the results of immu-
ylated in vivo by p300 (Gu and Roeder, 1997) following
noprecipitation and Western blotting presented in Fig-
either - or UV-irradiation (Liu et al., 1999; Sakaguchi eture 1A. Both the endogenous and the ectopically ex-
al., 1998; Abraham et al., 2000). After incubation withpressed hSir2 proteins detected in these assays
mSir2, we detected alterations of this oligopeptide sub-migrated as a protein species of 120 kilodalton (kDa)
strate by high-pressure liquid chromatography (HPLC).(Figure 1A). Immunofluorescent staining of the hSir2 pro-
As mentioned, the deacetylase activity of Sir2 utilizestein using our hSir2 antibody revealed nuclear localiza-
NAD as a cofactor (Smith et al., 2000). In the absencetion (Figure 1B).
of added NAD, incubation of mSir2 with the p53 oligo-To test for possible physical interactions between
peptide gave rise to a single prominent peak (peak 1)hSir2 and p53, we cotransfected the pYESir2wt plasmid
and a second, minor peak (peak 2) when the incubatedand a vector expressing wt p53 under the control of
material was analyzed by HPLC; these two peaks corre-the cytomegalovirus promoter (pCMV-wtp53) transiently
sponded to the monomeric and dimeric forms of theinto H1299 human lung carcinoma cells. These cells
acetylated peptide, respectively (Figure 2A). In contrast,have a homozygous deletion of the p53 gene (Mitsudomi
incubation of this oligopeptide and mSir2 in the pres-et al., 1992). Cell lysates were subsequently mixed with
ence of 1 mM NAD produced a singly deacetylated spe-the rabbit anti-hSir2 antibody and the resulting immune
cies as the major product (peak 3, Figure 2B). Edmancomplexes were collected and analyzed by immunoblot-
sequencing of this singly deacetylated species revealedting with the Ab-6 anti-p53 antibody (Figure 1D). As
that mSir2 preferentially deacetylated the residue cor-indicated in Figure 1D, immunoprecipitation of hSir2
responding to Lys382 of p53 (Figures 2E–2H) while hav-from lysates of these cotransfected cells resulted in
ing relatively little effect on the acetylated Lys373 resi-coprecipitation of p53. We also detected this interaction
due. Furthermore, a catalytically inactive mutant formreciprocally by using the Ab-6 anti-p53 antibody for im-
of mSir2, termed H355A, was unable to deacetylatemunoprecipitation and our anti-hSir2 antibody for prob-
the acetylated p53 peptide (Figure 2D). Like the H363Ying of the blotted precipitate (Figure 1C). These observa-
mutant version of hSir2, this H353A mutant carries ations provided the first indications that hSir2 and p53
substitution in residue 353, in this case an alanine incan form physical complexes with one another in vivo.
We also determined whether hSir2 could form com- place of the normally present histidine. These results
Deacetylation of p53 by Human Sir2
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Figure 1. Coprecipitation of hSir2 and p53 Protein
(A) Immunoprecipitation of hSir2 followed by immunoblotting with the same antibody revealed the existence of a 120 kDa protein in normal
BJ fibroblasts, and increased levels in these cells expressing the wild-type and HY mutant of hSir2.
(B) Immunofluorescence analysis of hSir2 indicated the existence of a nuclear protein with a nuclear staining pattern.
(C) p53 protein was immunoprecipitated with the Ab-6 (DO-1) anti-p53 antibody from lysates as shown, the blot was probed with anti-hSir2
antibody.
(D) Nuclear lysates from H1299 cells, BJ, Saos2, and MCF-7L were precipitated with the anti-hSir2 antibody. The blot was probed with the
anti-p53 antibody Ab-6. H1299 cells were ectopically expressing hSir2 and wt p53.
provided evidence that the acetylated p53 peptide could We used this system to determine whether hSir2 could
deacetylate the ectopically expressed p53 protein at itsserve as a substrate for mSir2 and indicated that the
de-acetylation of p53 at Lys382 by mammalian Sir2 is K382 residue in H1299 cells. To gauge the levels of
acetylation of p53 at Lys382, we used a rabbit polyclonalspecific and not the result of an indiscriminate deacety-
lase function. antibody, termed Ab-1 which had been raised against
the acetylated K382 of p53 protein. Its specificity had
been validated previously (Sakaguchi et al., 1998).Deacetylation of p53 by hSir2 In Vivo
Introduction of the CMVp53 plasmid expressing wild-We proceeded to test the ability of hSir2 to deacetylate
type p53 into the H1299 cells confirmed that p53 proteinfull-length p53 protein in vivo. Previous studies had
in these cells is acetylated at K382, as demonstratedshown that acetylated p53 can be produced in vivo by
by probing the immunoblot with the Ab-1 antibody (Fig-cotransfection of a p53 expression plasmid together
ure 3A, lanes 3, 6). Recognition of this acetylated formwith one expressing p300 in the absence of exposure
of p53 by the Ab-1 antibody was specific, since a mutantto DNA-damaging agents (Luo et al., 2000). We have
K382A p53 protein was not recognized by the Ab-1 anti-found, however, that under our conditions of transient
body (Figure 3A, lane 2).transfection, ectopically expressed p53 is acetylated,
Cotransfection of the hSir2- and p53-expression plas-even in the absence of ectopically expressed p300 acet-
mids substantially decreased the acetylated p53 thatylase (Figure 3). We suspect that the transfection proce-
could be detected by the Ab-1 antibody (Figure 3A,dure may induce a DNA damage response, likely due
lane 4). The residual amount of acetylated p53 could beto fragmented DNA introduced into the cells during this
further reduced by increasing the dose of cotransfectedprocedure, and that this damage response causes en-
hSir2 expression plasmid (lane 5).dogenous cellular acetylases, notably p300, to modify
Since the overall level of p53 was largely unaffectedthe ectopically expressed p53. We took advantage of
by ectopic expression of hSir2 (Figure 3A), we concludedthe resulting acetylated p53 in subsequent experiments,
that hSir2 acts in vivo to specifically reduce the level ofsince it allowed us to assess the influence of hSir2 on
the K382 acetylated form of p53. In light of the previouslyacetylated p53 in the presence of endogenous, physio-
logically relevant concentrations of p53 acetylases. demonstrated deacetylase activity of hSir2, we con-
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Figure 2. Effect of hSir2 Expression on p53
Acetylation In Vitro
The deacetylation activity of mSir2 on the
human p53 C-terminal peptide (residues 368-
386) diacetylated at positions 373 and 382.
(A and B) HPLC chromatograms of products
of deacetylation assays with mSir2. (C) HPLC
chromatogram of wild-type mSir2 in absence
of NAD as a control for (D). (D) HPLC chroma-
tograms of products from a mutant mSir2
protein in presence of NAD. (C) and (D) are
from a different set of HPLC analysis per-
formed independently from that for (A) and
(B). Peaks 1 and 2 correspond to the mono-
meric and dimeric forms of the p53 peptide,
respectively. Peak 3 corresponds to the sin-
gly deacetylated monomer identified by mass
spectroscopy. (E–H) Amino-terminal Edman
sequencing of peaks 1 and 3. Chromato-
grams of positions 373 and 382 are shown.
Peaks of acetyl-lysine (AcK) and simple lysine
(K) are indicated in each panel. Small peaks of
lysine are due to residual fractions of previous
lysines at positions 372 and 381.
cluded further that this reduction of acetylated p53 lev- substrate specificity of hSir2 and not a nonspecific con-
sequence of its overexpression.els was achieved by the direct action of the hSir2 enzyme
on acetylated p53 substrate.
We also introduced into these H1299 cells the hSir2HY
vector which expresses the mutant, catalytically inactive Effects of TSA on hSir2
Detection of endogenous acetylated p53 in most cellhSir2. In our assay, this mutant failed to deacetylate p53
efficiently, indicating that the catalytic activity of the types is a difficult task due to the metabolic instability
of p53 protein and the resulting need to process andintroduced wild-type hSIR2 gene product was required
for specific deacetylation of p53 Lys382 (Figure 3A, lane analyze large amounts of extracted protein. It appears
that the deacetylase inhibitor trichostatin A (TSA) can7). However, we did observe a small amount of deacety-
lase activity at 2-fold higher hSir2HY plasmid concentra- increase the levels of acetylated p53 protein in cells
(Sakaguchi et al., 1998). This is likely due to inhibitiontions (lane 8).
Finally, as a measure of the substrate specificity of by TSA of non-hSir2 deacetylases that target p53 pro-
tein. At the same time, in vitro studies have indicatedhSir2, we gauged its effects on acetylated histone, spe-
cifically the acetylated lysine 9 residue of histone H3. that Sir2 belongs to a class of deacetylases that are
resistant to TSA inhibition (Imai et al., 2000). TogetherWe monitored H3 Lys9 acetylation through use of the
9671S monoclonal antibody which specifically recog- these observations suggested the usefulness of includ-
ing TSA in our in vivo assays. To confirm the resistancenizes histone H3 that is acetylated at this position (Ex-
perimental Procedures). hSir2 overexpression did not of hSir2 to this drug and examine the utility of using
TSA, we subjected MCF-7L (Experimental Procedures)alter the acetylation of histone H3Lys9 (Figure 3B).
Taken together, these results provide evidence that the cells and their derivatives infected with either con-
trol vector, hSir2wt or hSir2HY retroviral vectors to 6 Gydeacetylation of p53 Lys382 in vivo reflects a defined
Deacetylation of p53 by Human Sir2
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Figure 3. hSir2 Effects on p53 Acetylation
In Vivo
(A) Reconstitution of the acetylation and de-
acetylation in H1299 cells by transient co-
transfection. After cotransfection of the con-
structs, the cellular lysates were analyzed by
western blot analysis, using Ab-1 to detect
K382 p53, 6243 for total p53 or  actin for
loading control. Lanes 3, 6, CMVwtp53 by it-
self generates acetylated p53 at K382. Lane
2, tranfection of the acetylation mutant K382R
of p53. Lanes 4, 5, with cotransfected wild-
type hSir2. Lanes 7, 8, cotransfected mutant
hSir2HY.
(B) Similar to (A), except for Histone H3 acet-
ylation was assessed before and after addi-
tion of wild-type hSir2 and the mentioned
constructs.
(C) MCF-7LP, MCF-7LhSir2wt and MCF-
7LhSir2HY cells were treated with or without
0.1 M concentrations of TSA and subjected
to 6 Gy of ionizing radiation. Acetylated levels
of p53 were detected using Ab-1. Total p53
levels were measured using 6243 antibody
(bottom).
(D) BJT control cells and their derivatives
BJThSir2wt and BJhSir2HY were treated with
6Gy of ionizing radiaton. 1 mg of lysates were
immunoprecipitated with either a control
whole IgG fraction or with Ab-6. The resulting
immunoblot was probed with Ab-1 (top) for
acetylated p53 and for total p53 protein.
(E) BJT cells were stably infected with either
a wild-type expressing hSir2 or a mutant
hSir2HY virus. Cells were subjected to 6 Gy
of ionizing radiation in presence of low con-
centrations of TSA (0.1M), and the p53 acet-
ylation was measured at indicated time points
by immunoblotting with Ab-1 that recognizes
specifically the deacetylated K382 p53 pro-
tein. The blots were subsequently probed
with anti-p53, anti- actin and anti-hSir2 anti-
bodies. Time (hr) post 6 Gy of irradiation is
shown inside the brackets.
of ionizing radiation in the presence or absence of 0.1 fibroblasts that have been immortalized by ectopic ex-
M TSA. pression of the telomerase enzyme. We note that our
As indicated in Figure 3C, wild-type hSir2 was able previous studies indicated that expression of telo-
to efficiently deacetylate p53 either in the presence or merase in these cells, undertaken to extend their life
absence of TSA. In contrast, the mutant hSir2HY was span, had no effect on either the activation of p53 protein
unable to deacetylate p53. These results indicated that or on their responses to DNA damage (Vaziri et al., 1999).
TSA treatment did not affect the ability of hSir2 to de- We expressed either wild-type hSir2 or the mutant
acetylate its in vivo target, p53 protein. These results form specified by the hSir2HY vector in the BJT cells
also indicate that in vivo hSir2 acts as a TSA-resistant and examined subsequent responses to ionizing radia-
deacetylase. Having validated the use of TSA in our tion. To monitor the anticipated acetylation of p53, we
experiments, we proceeded to use this drug to facilitate used, as before, the Ab-1 antibody which recognizes
the investigation of the effect of hSir2 on p53 acetylation the acetylated p53 protein. Indeed, upon exposure of
following DNA damage. the cells to 6 Gy of ionizing radiation, we observed a
marked increase in the level of acetylated p53 protein
that could be immunoprecipitated by the Ab-6 antibodyhSir2 as an Antagonist of the Radiation-Induced
and detected by immunoblotting with the Ab-1 antibodyp53 Acetylation
(Figure 3D). This increase in acetylated p53 protein wasThe observation that p53 is acetylated at K382 raised the
blocked effectively in BJT cells that stably overex-question of whether hSir2 could antagonize and reverse
pressed wild-type hSir2. In contrast, cells expressing thethis acetylation of p53, doing so through its deacetylase
hSir2HY mutant protein showed acetylated p53 proteinfunction. We chose to investigate this possible interac-
tion in BJT cells, polyclonal derivatives of human BJ levels comparable to those of control BJT cells while
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the level of total immunoprecipitable p53 in these cells of p53, seen already at 2 hr post-irradiation, compared
to induction at 3–4 hr post-irradiation in control, parentalwas slightly decreased.
BJT cells. On the basis of these experiments, we con-
cluded that wild-type hSir2 protein is able to deacetylateEvidence for Dominant-Negative Effects of hSir2HY
p53 protein efficiently at the K382 residue. Moreover,on Acetylated p53 following DNA Damage
ectopic expression of a mutant hSir2HY protein at onlyExperiments in the previous section suggested that p53
4-fold above endogenous background levels of hSir2 isprotein can be deacetylated by hSir2 in BJT cells. How-
able to exert a significant dominant-negative effect.ever, these experiments did not address the kinetics
with which maximal acetylation/deacetylation at K382
residue occurs in the presence of wild-type or mutant Effects of hSir2 on the Transcriptional Activity
of p53 ProteinhSir2. We also wished to measure the levels of wild-
type and mutant hSir2 that were required to alter the We also investigated the possible effects of hSir2 on
the activity of p53 as a transcription factor. To do so,acetylated state of p53 in the BJT cells ectopically ex-
pressing one or the other of these hSir2 proteins. we cotransfected H1299 cells transiently with a p53 ex-
pression plasmid and a reporter construct in which theTo address these issues, we exposed the BJT cells
and their derivatives to 6 Gy of ionizing radiation in the promoter of the p21WAF1 gene (el-Deiry et al., 1993), a
known target of transcriptional activation by p53, drivespresence of 0.1 M TSA. We subsequently collected
cells before irradiation and at five time points post-irradi- expression of a luciferase reporter gene (Vaziri et al.,
1997). As indicated in Figure 4A, luciferase activity in-ation. Cells were lysed and equal amounts of protein
were resolved by gel electrophoresis and then trans- creased in response to increasing amounts of cotrans-
fected wild-type p53 expression vector. Conversely, theferred to immunoblots. As in earlier experiments, we
used as a probe in these immunoblots the polyclonal activity of the p21 promoter was suppressed in a dose-
dependent fashion by coexpression of wild-type hSir2.rabbit antiserum (Ab-1) which specifically recognizes
the acetylated K382 form of p53. These blots were se- We note that there remains a possibility that hSir2 can
also suppress the p21 promoter in a p53-independentquentially reprobed with a polyclonal p53 antibody, with
a  actin antibody as a loading control, and with the fashion, since luciferase activity was also reduced below
that of the control (lane 1) cells in which no ectopicanti-hSir2 antibody.
As anticipated, following 6 Gy of ionizing radiation p53 was expressed. The catalytically inactive hSir2HY
mutant had no effect on the activity of this promoterwe observed a 1.5- to 2-fold increase in the level of
acetylated p53 protein, indicated by the level of p53 (Figure 4A). To gauge the specificity of hSir2 in affecting
promoter activity, we used as control a constitutivelyprotein recognized by the Ab-1 antiserum (Figure 3E).
A 4-fold increase in hSir2 level, achieved through ectopic active SV40 promoter linked to the luciferase gene. Ex-
pression of this control construct was not affected byexpression of hSir2, sufficed to block the radiation-
induced increase in acetylated K382 p53 protein (Figure increasing amounts of the hSir2 vector expressed at any
level (Figure 4B).3E). In contrast, we observed that the ectopic expres-
sion at comparable levels of the catalytically inactive The above experiments relied on ectopic gene expres-
sion and may not necessarily reflect how p21WAF1expres-hSir2HY increased the radiation-induced levels of p53
acetylated at residue K382 (Figure 3B). This observation sion is affected by hSir2 under more physiologic condi-
tions including exposure to ionizing radiation. Toprovided support for the notion that the hSir2HY mutant
protein was able to act in a dominant-negative fashion address this issue, we used MCF-7L cells cultured in
the absence of TSA. Like the parental MCF-7 cells, thosein BJT cells.
We considered it possible that the observed inhibition from the MCF-7L subline can induce p53 protein nor-
mally in response to radiation. These cells were infectedof acetylated p53 described above might be attributable
to a reduction in the levels of total p53 in these cells. stably with the retroviral vectors expressing wild-type
hSir2 and dominant-negative hSir2HY. We then exposedHowever, a reprobing of this immunoblot with a poly-
clonal anti-p53 antibody showed normal stabilization of these cells to 6 Gy of ionizing radiation and subsequently
measured total p53 and p21WAF1 protein levels (Figurep53 in control cells in response to DNA damage and at
most very slightly reduced steady-state levels of p53 in 4C). p53 protein levels increased normally in these poly-
clonal cell populations in response to irradiation. Athe presence of ectopically expressed wild-type hSir2
(Figure 3E). This lower level of p53 could not account 4-fold overexpression of wild-type hSir2 resulted in a
slight but clearly detectable decrease of p21WAF1 proteinfor the much larger decrease in acetylated p53 observed
in the presence of wild-type hSir2. Moreover, the mutant in these cells (Figure 4C). This decrease was not suffi-
cient to abrogate the p53-dependent G1 checkpoint ashSir2HY also reduced the stability of p53 protein slightly
despite its ability to cause increased acetylation of this measured by analysis of DNA content (data not shown).
In contrast, the levels of p21WAF1 protein in irradiatedprotein (Figure 3E). Hence, while hSir2 was able to re-
verse the radiation-induced acetylation of p53 in these MCF-7L cells expressing the hSir2HY protein were sig-
nificantly (3-fold) higher when compared with parentalcells, it had only minimal effects on the steady state
level of p53 induced by exposure to radiation. MCF-7LP cells infected with an empty control vector.
Consistent with this effect on p21 protein levels, weWe also made several observations regarding the ki-
netics of p53 acetylation (Figure 3E). Ectopic expression found that measurements of the K382-acetylated frac-
tion of p53 in lysates of irradiated hSir2HY-expressingof hSir2 was able to efficiently block p53 acetylation. In
contrast, expression of the mutant hSir2HY in BJT cells MCF-7LP cells showed a large increase when compared
with the irradiated controls that did not express hSir2HYhad the opposite effect: it caused premature induction
Deacetylation of p53 by Human Sir2
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Figure 4. hSir2 Expression and Its Influence on p53 Activity and p21WAF1
(A) Transcriptional activity of p53 protein was measured in H1299 cells by cotransfection p53 with a p21WAF1 promoter-luciferase construct
(p21Pluc) and hSir2wt or hSir2HY.
(B) A control SV40-Luciferase was cotransfected with CMVp53 and increasing amounts of wild-type hSir2 into H1299 cells and luciferase
activity was measured.
(C) Levels of p21WAF1 in MCF-7L cells expressing wt hSir2 or hSir2HY protein in response to 6 Gy of ionizing radiation in absence of TSA. The
blot was probed with Ab-6 for detection of total p53 and  actin for loading control.
(D) Deacetylation of p53 in vivo in MCF-7LP cells. Ectopic expression of wild-type hSir2 or hSir2HY mutant in MCF-7L cells radiated with 6
Gy of ionizing radiation and its effect on p53 acetylation at K382. 1 mg of total protein lysates was subjected to immunoprecipitation with
Ab-1 (top panel), and the blot was probed for p53 with Ab-6. The remaining lysates were immunoprecipitated with SC6423 polyclonal rabbit
antibody for total p53 protein, and the resulting p53 in the precipitate was detected by Ab-6 (second panel). Equal amounts of protein from
the aforementioned experiment were also quantified to ensure equal total protein was loaded and that total p53 levels were comparable to
each other using Ab-6 and  actin antibodies.
(Figure 4D, upper panel). Furthermore, immunoprecipi- wt p53-expressing vector, induces apoptosis as gauged
tation with a polyclonal anti-p53 rabbit antibody of these by the display of the cell surface annexin V antigen
lysates, following depletion by incubation with the Ab-1 (Figure 5A). The apoptotic response in H1299 cells trans-
antibody indicated that the majority of p53 in the irradi- fected with p53 was potentiated in a dose-dependent
ated MCF-7LhSir2HY cells was in an acetylated state manner in cells cotransfected the dominant-negative
(Figure 4D). Taken together, these experiments con- hSir2HY expression plasmid. Expression of hSir2 on its
verged on the conclusion that the hSir2HY mutant func- own did not significantly change the level of apoptosis.
tions as a dominant-negative protein by quantitatively Although this assay is accepted widely for measuring
inhibiting the p53 deacetylation at K382. p53-dependent apoptosis, it relies on ectopic expres-
sion of p53 under nonphysiologic conditions. In order
to address this problem, we made use of BJT cells whichPotentiation of p53-Dependent Apoptosis
contain a functional endogenous p53 protein. Theseby hSir2HY
cells undergo p53-dependent apoptosis upon exposureGiven that dominant-negative inhibition of hSir2 can po-
to high concentration of the chemotherapeutic drug VP-tentiate the ability of p53 to induce p21WAF1, we sought
16 (etoposide), that induces double-strand DNA breaksto ascertain whether hSir2 inhibition could potentiate
(Figure 5B). Exposure of BJT and BJThSir2HY cells top53-dependent apoptosis. To address this possibility,
40 M VP-16 and TSA induced apoptosis, as gaugedwe relied on the fact that restoration of wild-type p53
function in H1299 cells, achieved via introduction of a by the display of the cell surface annexin V antigen
Cell
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Figure 5. Effects of hSir2 on p53-Dependent
Apoptosis and Radiosensitivity
(A) Ectopic expression of hSir2HY and its
dose-dependent influence on p53-depen-
dent apoptosis in H1299 cells. H1299 cells
were transfected with a wild-type p53 expres-
sion construct to induce p53-dependent apo-
ptosis. Annexin V positive and propidium io-
dide negative cells were measured after 48 hr.
(B) BJT and BJThSir2HY cells were exposed
to 40 M VP16 in presence of TSA and p53-
dependent apoptosis was measured as in (A)
after 72 hr. Ctrl (BJT cells), DD (BJT cells ex-
pressing dominant-negative p53DD), HY
(BJThSir2HY cells), H/D (BJThsir2HY cells ex-
pressing dominant-negative p53DD).
(C) Comparison of -ray survival. Dose-
response curves are shown for different types
of BJ cells treated with ionizing radiation
while growing exponentially and asynchro-
nously. Twelve days after radiation the colo-
nies were counted and survival calculated.
(Figure 5B). We found that expression of hSir2HY in expression of the mutant hSir2HY sensitized BJT cells to
radiation. As anticipated, control ataxia-telangiecstasiaBJT cells potentiated apoptosis by VP-16 significantly.
Ectopic expression of a dominant-negative p53 con- cells were found to be highly radiosensitive (Figure 5C).
The specific role played by p53 in these variousstruct reduced hSir2HY-induced apoptosis, indicating
its dependence on p53 function. These results indicated survival responses was demonstrated by the behavior
of three sublines of BJT fibroblasts that expressed athat hSir2HY specifically potentiated apoptosis induced
by DNA damage. Moreover, these observations are con- dominant-negative form of p53 (Shaulian et al., 1992) in
addition to either hSir2wt, hSir2HY, or a control vector.sistent with our previous results indicating that hSir2HY
potentiates p53 function via inhibition of deacetylation. Expression of the DNp53 construct abrogated the radio-
sensitive behavior of BJhSir2HY cells and rendered
them once again radioresistant. This provided strongEffects of Mutant hSir2HY on Radiosensitivity
evidence that the dominant-negative behavior of hSir2HYof Human Fibroblasts
in BJT cells is dependent on p53 function. Moreover,Human fibroblasts become relatively radioresistant
these responses support the previous conclusion thatupon loss or inactivation of their p53 function (Tsang et
the hSir2HY mutant specifically potentiates the activityal., 1995). This behavior suggested an additional test of
of p53 protein.the ability of hSir2 to antagonize p53 function, which
depended on measuring the long-term survival of human
BJT fibroblasts cells following exposure to various Discussion
doses of low-level ionizing radiation. Ectopic expression
of wild-type hSir2 to a level 4-fold above that of the The SIR2 complex in S. cerevisiae was originally identi-
fied through its involvement in the maintenance of chro-endogenous protein in these irradiated cells had no sig-
nificant effect on long-term survival (Figure 5C), while matin silencing at mating type loci and telomeres. It is
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composed of three component subunits, Sir2-4p, which tions may involve overexpression of hSir2 which, like
are normally found localized to yeast telomeres. In re- the other two genetic strategies, should contribute to
sponse to DNA damage, the SIR complexes relocate to the inactivation of p53. Furthermore, chemical inhibition
the site of double-strand breaks where they participate of deacetylases like hSir2 may potentiate apoptosis of
in the repair of these lesions. This DNA damage re- tumor cells that have been challenged with DNA dam-
sponse is dependent on the function of the MEC1/RAD9 age-inducing drugs.
DNA checkpoint pathway. MEC1 is related to the ATM
protein which coordinates the DNA damage response Experimental Procedures
in mammalian cells, in part by triggering the cascade of
Cell Culture and Derivation of Cell Linesevents that lead to stabilization of the p53 protein.
All cells were grown in presence of 20% O2 and 5% CO2 at 37C inDouble-strand DNA breaks in the genomes of mam-
humidified chambers. BJ cells, MCF-7, and H1299 were grown inmalian cells trigger a cascade of signaling events that
DME 10% FCS. PBS(/) (phosphate buffered saline) without
ultimately result in phosphorylation and subsequent sta- magnesium or calcium was used in this work.
bilization of the p53 protein. In addition, these breaks Amphotrophic viruses were produced by transient cotransfection
lead to activation of p53 protein as a transcription factor. of pCL-Ampho with the LTR-containing pBabe vectors (Morgenstern
and Land, 1990), pYESir2 or pYESir2HY in to 293T cell line usingThis functional activation depends in substantial part
Fugene6 (Roche). Primary BJ cells or MCF-7L cells were infectedon its acetylation. The resulting stabilized, activated p53
with retrovirus containing media in presence of 8g/ml of polybreneprotein contributes to the upregulation of the cyclin-
overnight. 48 hr later cells were selected in puromycin at 1g/ml and
dependent kinase inhibitor p21WAF1 and thus to the cyto- 5 g/ml, respectively. These selected BJ cells were subsequently
static effects of p53. Alternatively, depending on the infected and selected with a pBabe-hTERT virus carrying the hygro-
cellular background and the degree of DNA damage, mycin resistance gene (200 g/ml). The resulting cells were: BJT
(carrying pBabe control vectors), BJThSir2wt (carrying pYESir2 andthe proapoptotic effects of p53 may predominate.
pBhTERT) and BJThSir2HY (pYESir2HYand pBhTERT). MCF-7 cellsThese various phenomena indicate that specific com-
were transfected with the vector p21P-luc (Vaziri et al., 1997) andponents of the machinery that monitor the integrity of
pCMVneo, clones were selected in 500 g/ml of G418 and the clonethe genome are able to alert p53 to the presence of
designated MCF-7L was selected that was able to upregulate the
genetic damage and cause its functional activation. p21WAF1 promoter-luciferase in response to treatment with 6 Gy of
Conversely, in the event that damage has been success- ionizing radiation. MCF-7L cells were infected with the same viruses
fully repaired, signals must be conveyed to p53 in order as described before to yield the following cell lines: MCF-7LP (car-
rying pBabe Y-puro backbone), MCF-7L-hSir2wt, and MCF-7L-to deactivate it. Thus, a blockage of cell cycle progres-
hSir2HY. Cells were kept under appropriate selection throughoutsion that has been imposed by p53 in order to allow
experiments.DNA repair to proceed must be relieved following com-
pletion of repair, enabling the cell to return to its active
Isolation of hSIR2SIRT1 Genegrowth state. In such a situation, the inactivation of p53
hSIR2SIRT1 gene was obtained by PCR amplification using 5 primer-1becomes as important physiologically as its activation.
GGATCCACCATGGCGGACGAGGCGGCCCTCGCC and 3 primer-2
In the present work, we have observed that hSir2 GTCTAGAGTGGAACAATTCCTGTACCTGCAC from a human spleen
directly binds the human p53 protein in vivo and specifi- Marathon cDNA library (Clontech) to obtain a majority of the hSIR2SIRT1
cally deacetylates the K382 residue of p53. One of the cDNA including the C terminus. Due to GC-rich nature of the 5 end
of hSIR2SIRT1, we used a human genomic clone (Accession number:observed functional consequences of this deacetylation
AL133551, clone RP11-57G10) as a template to obtain the 5 end.is an attenuation of the p53 protein’s activity as a tran-
We used 10 PCR cycles using pfu-turbo PCR (denaturation at 98C,scription factor at the p21WAF1 promoter. In other cellular
1M betaine and 10% DMSO were added to the stratagene pfu buffer)contexts, in which the DNA damage response leads
using Primer-1 and Primer-3, GAGGAGGAGATGCGCAGTTCCGGC
to apoptosis, hSir2 activity inhibits the p53-dependent CGCCC. The PCR product was cloned into pcr4blunt-TOPO (In-
apoptotic response (Luo et al., 2001). vitrogen) and sequenced. This exon-1 on hSIR2SIRT1 was used to
With these observations in mind, we propose that complete the sequence of hSIR2SIRT1 amplified previously by PCR.
To generate the hSir2H363Y mutant, the PCR overlap primer methodin mammalian cells, signals indicating the successful
was used to create the point mutation (CAT to TAT) at codon 363.completion of DNA repair are relayed via hSir2 to acet-
ylated proteins like p53 that have been charged with
Construction of Expression Plasmidsthe task of imposing a growth arrest following DNA dam-
A BamHI/SnaBI fragment of hSIR2SIRT1 cDNA isolated from a cDNAage. In some way, these signals enable hSir2 to reverse
library (Clontech) was inserted into pBabe-Y-Puro, the resultingin part the damage-induced activation of p53 by deacet-
plasmid was called pYESir2-puro. Similarly a BamHI/SnaBI fragmentylating the K382 residue of p53. In doing so, hSir2 in of hSir2 that was mutated at residue 363 from Histidine (H) to Tyro-
collaboration with other deacetylases reduces the likeli- sine (Y) by site-directed mutagenesis (Stratagene) was used to cre-
hood of subsequent apoptosis and, at the same time, ate the retroviral vector pYESir2HY. pBhTERT contained an EcoRI/
makes it possible for cells to return to the physiological SalI fragment of hTERT cloned into EcoRI/SalI site of pBabe-Hygro.
state they enjoyed prior to sustaining damage to their
genomes. Immunoblot Analysis
Alterations of the p53 signaling pathway are presumed For detection of acetylated forms of p53 in BJT cells and MCF-7L
cells, we plated an equal number of cells 24 hr before the experiment.to be found in most human tumors (Hollstein et al., 1994).
1.5 	 106 BJT cells or 107 MCF-7L were exposed to 6 Gy of ionizingIn about half of these tumors, mutation of the p53 gene
radiation (137Cesium). Cell pellets were frozen on dry ice at the appro-suffices to derail function. In some of the remaining
priate time point. These pellets were lysed on ice at once by adding
tumors, loss of p14ARF, which acts to downregulate p53 0.5% NP40, 150 mM NaCl, 50 mM Tris in presence of protease
protein levels, has been implicated. The present obser- inhibitor mix (Roche), for 30 min, and vortexing. Cell lysates were
vations raise the possibility that a third mechanism by prepared by centrifugation for 20 min at 4C. Protein content of
lysates were measured by BioRad DC protein assay. 300 g of pro-which an incipient cancer cell can rid itself of p53 func-
Cell
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tein was resolved on gradient 4%–20% criterion Tris-HC gels (Bio- tion. We also thank the Jose´ Carreras International Leukemia Foun-
dation for fellowship support to HV.rad), transferred to nitrocellulose and blocked in 10% skim milk.
The resulting membrane was incubated overnight in 1:400 dilution
of (PAbLys(Ac)382) (termed here Ab-1) (Oncogene Science, peptide Received May 30, 2001; revised September 18, 2001.
based rabbit polyclonal anti K382 p53). This membrane was then
washed twice in PBS(/) containing 0.05% Tween 20 for 15 min.
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